Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can calcitonin and carcinoembryonic antigen doubling times predict progression of thyroid carcinoma?

Nature Clinical Practice Endocrinology & Metabolism volume 4, pages 428–429 (2008)Cite this article

boxed-textGiraudet AL et al. (2008) Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times. Eur J Endocrinol 158: 239–246

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. de Groot JW et al. (2006) Biochemical markers in the follow-up of medullary thyroid cancer. Thyroid 16: 1163–1170

    Article  CAS  Google Scholar 

  2. You YN et al. (2006) Medullary thyroid cancer. Surg Oncol Clin N Am 15: 639–660

    Article  Google Scholar 

  3. Miyauchi A et al. (1984) Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma. Ann Surg 199: 461–466

    Article  CAS  Google Scholar 

  4. Barbet J et al. (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90: 6077–6084

    Article  CAS  Google Scholar 

  5. Ong SC et al. (2007) Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med 48: 501–507

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. J Klopper is an Assistant Professor of Medicine and B Haugen is a Professor of Medicine and Pathology in the Division of Endocrinology, Metabolism and Diabetes, University of Colorado Denver–Anschutz Medical Campus, Aurora, CO, USA.,

    Joshua Klopper & Bryan Haugen

Authors
  1. Joshua Klopper
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bryan Haugen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joshua Klopper.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Klopper, J., Haugen, B. Can calcitonin and carcinoembryonic antigen doubling times predict progression of thyroid carcinoma?. Nat Rev Endocrinol 4, 428–429 (2008). https://doi.org/10.1038/ncpendmet0865

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0865

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing